Qing Wang, MD, PhD

Our Providers

Academic Appointments

  • Assistant Professor of Ophthalmology
Qing Wang, MD, PhD

Qing Wang, MD, PhD, is an Assistant Professor of Ophthalmology. She is a glaucoma-trained clinician-scientist who studies retinal ganglion cell and astrocyte biology in the context of glaucoma pathogenesis, neuroprotection, and neuronal regeneration.

Dr. Wang graduated with a BS and MS in Molecular Biophysicis and Biochemistry from Yale University, where she was initiated into neuroscience research, investigating the role of cell adhesion molecules in mammalian synaptogenesis under the tutelage Dr. Thomas Biederer. She subsequently came to Columbia University, where she earned her MD and PhD through the Medical Scientist Training Program and Doctoral Program in Neurobiology and Behavior, under the mentorship of Dr. Carol Mason. Her doctoral dissertation explored the different molecular pathways that specify and guide the growth of ipsilaterally and contralaterally projecting retinal ganglion cells throughout the development of the mammalian binocular visual pathways. She uncovered not only genes that define these two cell populations but also a novel group of progenitor cells at the ciliary margin zone that give rise to ipsilateral RGCs. Following her MD/PhD training, Dr. Wang joined the EyeSTAR program at Stein Eye Institute of the University of California, Los Angeles, where she completed a combined ophthalmology residency and postdoctoral research fellowship under the mentorship of Dr. Thomas Carmichael. Her postdoctoral work focused on activity-dependent molecular mechanisms in optic nerve regeneration after injury.

At Columbia, Dr. Wang is using viral and transcriptomic approaches to understand how retinal ganglion cell and astrocyte interactions at the optic nerve head drive retinal ganglion cell loss in mouse glaucoma models. While astrocytes have been shown to play both neuroprotective and neurotoxic roles in disease, their role in the pathogenesis of glaucoma remains unclear. Her research has the potential to develop novel genetic and molecular therapies for the treatment of glaucoma. As a clinician-scientist, Dr. Wang continues to take care of glaucoma patients clinically and surgically and is also involved in ongoing clinical research studies in the glaucoma division.

Lab Locations

  • CUIMC/Edward S. Harkness Eye Institute

    635 West 165th Street
    New York, NY 10032